首頁 > 市場調查報告書 > 食物/飲料

醫用食品市場規模、佔有率和成長分析（按給藥途徑、產品、銷售管道、應用和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1903056

醫用食品市場規模、佔有率和成長分析（按給藥途徑、產品、銷售管道、應用和地區分類）－2026-2033年產業預測

Medical Foods Market Size, Share, and Growth Analysis, By Route of Administration (Oral, Enteral), By Product (Powder, Pills), By Sales Channel, By Application, By Region -Industry Forecast 2026-2033.

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，醫用食品市場規模將達到 250.2 億美元，到 2025 年將達到 263.2 億美元，到 2033 年將達到 394.8 億美元，預測期（2026-2033 年）的複合年成長率為 5.2%。

由於阿茲海默症、注意力不足過動症（ADHD）和各種中樞神經系統疾病等慢性疾病的發生率不斷上升，特殊醫學用途配方食品市場正經歷顯著成長。此外，醫療專業人員建議有特定營養需求的患者使用胺基酸經腸營養，以解決睡眠障礙、憂鬱症和創傷後壓力症候群（PTSD）等問題。藥物研發的進步推動了疾病特異性配方的出現，進一步促進了這個細分市場的發展。主要企業正主導個人化臨床營養的發展，為各種健康挑戰提供量身訂製的解決方案。與一般營養補充品不同，特殊醫學用途配方食品要經過類似藥品的嚴格測試，以確保其對特定疾病的療效。這種全面的檢驗流程，結合專家的建議，正在提高消費者對特殊醫學用途配方食品的認知度和接受度。

全球醫用食品市場按給藥途徑、產品類型、銷售管道、應用領域和地區進行細分。依給藥途徑分類，市場分為口服和腸內給藥；按產品類型分類，市場分為粉劑、片劑、液體和其他劑型；按最終用戶分類，市場分為線上銷售、零售和機構銷售；按應用領域分類，市場分為慢性腎臟病、輕度肝性腦病變、化療引起的腹瀉、病原體相關感染疾病、糖尿病神經病變、注意力不足過動症（ADHD）、憂鬱症、阿茲海默症、營養缺乏症、罕見疾病、創傷治療和其他疾病；按地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

醫用食品市場的成長要素

在全球範圍內，糖尿病、心血管疾病和代謝紊亂等慢性疾病的發生率不斷上升，是推動特殊醫學用途配方食品需求成長的主要因素。這些特殊營養產品滿足具有特定營養需求的人群，並在疾病管理中發揮至關重要的作用。透過提供個人化的營養支持，特殊醫學用途配方食品有助於緩解症狀、改善整體健康狀況，並提高患者的生活品質。隨著越來越多的人尋求有效的飲食方法來應對自身獨特的健康挑戰，人們對飲食在慢性疾病管理中的重要性認知不斷提高，這也進一步促進了特殊醫學用途配方食品市場的擴張。

醫用食品市場的限制

特殊醫學用途配方食品市場面臨的主要挑戰之一是醫護人員、患者及其看護者對特殊醫學用途配方食品的益處和重要性缺乏了解。有效的溝通和教育在推廣和普及特殊醫學用途配方食品方面發揮著至關重要的作用。許多醫護人員並不完全了解特殊醫學用途配方食品、膳食補充劑和普通食品之間的區別，這可能會對處方流程以及最終患者的健康產生負面影響。這種知識差距阻礙了特殊醫學用途配方食品的合理使用，導致錯失改善患者療效的機會，並使人們對特殊醫學用途配方食品在膳食管理和治療中的作用有了更深入的了解。

醫用食品市場趨勢

隨著醫療服務提供者日益認知到營養干預在治療糖尿病、阿茲海默症和胃腸道疾病等疾病中的重要作用，醫用食品市場正經歷著向慢性病管理方向的顯著轉變。這一市場轉變強調將醫用食品融入旨在改善代謝途徑和營養缺乏的綜合護理策略中。預防性照護日益重要，使得醫用食品不再只是膳食補充劑，而是成為治療方案的關鍵組成部分。這種方法促進了醫學治療和營養治療的融合，並將醫用食品定位為以患者整體健康為導向的創新醫療保健解決方案的關鍵要素。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Danone
Nestle
Abbott
Targeted Medical Pharma Inc.（Physician Therapeutics LLC, a division of the company）
Primus Pharmaceuticals Inc.
Fresenius Kabi AG
Kate Farms
Ajinomoto Cambrooke
Nutricia North America
GlaxoSmithKline
B. Braun Medical Inc.
BioCare
NutriScience Innovations
Ajinomoto Health & Nutrition
Baxter International
Fresenius Kabi

結論與建議

簡介目錄

Product Code: SQMIG35I2345

Medical Foods Market size was valued at USD 25.02 Billion in 2024 and is poised to grow from USD 26.32 Billion in 2025 to USD 39.48 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The market for medical foods is witnessing substantial growth due to the rising incidence of chronic conditions such as Alzheimer's, ADHD, and various central nervous system disorders. Additionally, medical professionals advocate for amino acid-based enteral nutrition to manage issues like sleep disorders, depression, and PTSD, catering to patients with specific nutritional needs. The emergence of targeted disease-specific formulas, driven by advancements in drug development, further fuels this market segment. Prominent companies are leading the charge in personalized clinical nutrition, offering tailored solutions for diverse health challenges. Unlike standard dietary supplements, medical foods undergo rigorous testing akin to pharmaceuticals, ensuring their efficacy for specific medical conditions. This thorough validation process, along with professional recommendations, enhances the appeal and acceptance of medical foods among consumers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Medical Foods market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Medical Foods Market Segments Analysis

Global Medical Foods Market is segmented into Route of Administration, Product, Sales Channel, Application, and region. By animal type, the market is classified into Oral, and Enteral. Depending on the product, it is categorized into Powder, Pills, Liquid, and Other. According to end user, the market is divided into Online Sales, Retail Sales, and Institutional Sales. By Application, the market is segmented into Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy Induced Diarrhoea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases, Wound Healing, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Medical Foods Market

The rising incidence of chronic conditions such as diabetes, cardiovascular diseases, and metabolic disorders worldwide is significantly driving the demand for medical foods. These specialized dietary products cater to individuals with specific nutritional needs, playing a crucial role in managing their health conditions. By providing tailored nutritional support, medical foods help alleviate symptoms, improve overall health outcomes, and enhance the quality of life for patients. The growing awareness of the importance of diet in managing these chronic illnesses further contributes to the expanding market for medical foods, as more people seek effective dietary therapies to address their unique health challenges.

Restraints in the Medical Foods Market

A significant challenge in the Medical Foods market is the lack of awareness among medical professionals, patients, and caregivers regarding the benefits and importance of medical foods. Effective communication and education play a crucial role in fostering acceptance and encouraging adoption. Many healthcare practitioners may not fully grasp the distinctions between medical foods, dietary supplements, and conventional foods, which can adversely affect the prescribing process and ultimately impact patient health. This knowledge gap can hinder the proper utilization of medical foods, leading to missed opportunities for improving patient outcomes and complicating the overall understanding of their role in dietary management and treatment.

Market Trends of the Medical Foods Market

The Medical Foods market is witnessing a notable trend towards chronic disease management, as healthcare providers increasingly recognize the role of nutritional interventions in treating conditions such as diabetes, Alzheimer's, and gastrointestinal disorders. This market shift emphasizes the integration of medicinal foods into comprehensive care strategies aimed at addressing metabolic pathways and nutritional deficiencies. As preventative healthcare gains traction, medical foods are being viewed not just as dietary supplements but as critical components of therapeutic regimens. This approach fosters the convergence of medical and nutritional therapies, positioning medical foods as a vital element in innovative healthcare solutions focused on holistic patient outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Value Chain Analysis
Case Study Analysis
PESTEL Analysis
Macro-Economic Indicators
Market Attractiveness Index
Pricing Analysis

Global Medical Foods Market Size by Route of Administration & CAGR (2026-2033)

Market Overview
Oral
Enteral

Global Medical Foods Market Size by Product & CAGR (2026-2033)

Market Overview
Powder
Pills
Liquid
Other

Global Medical Foods Market Size by Sales Channel & CAGR (2026-2033)

Market Overview
Online Sales
Retail Sales
Institutional Sales

Global Medical Foods Market Size by Application & CAGR (2026-2033)

Market Overview
Chronic Kidney Disease
Minimal Hepatic Encephalopathy
Chemotherapy Induced Diarrhoea
Pathogen Related Infections
Diabetic Neuropathy
ADHD
Depression
Alzheimer's Disease
Nutritional Deficiency
Orphan Diseases
- Tyrosinemia
- Eosinophilic Esophagitis
- FPIES
- Phenylketonuria
- MSUD
- Homocystinuria
- Others
Wound Healing
Others

Global Medical Foods Market Size & CAGR (2026-2033)

North America, (Route of Administration, Product, Sales Channel, Application)
- US
- Canada
Europe, (Route of Administration, Product, Sales Channel, Application)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Route of Administration, Product, Sales Channel, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Route of Administration, Product, Sales Channel, Application)
- Brazil
- Rest of Latin America
Middle East & Africa, (Route of Administration, Product, Sales Channel, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Danone
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nestle
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Primus Pharmaceuticals Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kate Farms
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ajinomoto Cambrooke
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nutricia North America
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Medical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioCare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NutriScience Innovations
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ajinomoto Health & Nutrition
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments